ARCHIVES

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

Two Cooperative Groups Renamed ECOG-ACRIN

September 23, 2011

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

Chemotherapy Patients Can Benefit From Heart Failure Treatment, Study Finds

October 25, 2002

Court Orders NIH To Retract Electronic Annotations On Fisher Publications

March 24, 1995